FDA Inspection
Integrity Biosurgical Systems, Inc.Integrity Biosurgical Systems, Inc. – FDA Inspection, May 2, 2022
Record Details
This FDA Inspection record concerns Integrity Biosurgical Systems, Inc., with an inspection on May 2, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 2, 2022
- Product Type
- Biologics
View Company Profile
ID · 872bac56-9ac3-48ea-813f-0f7963d2723c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1169041
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Integrity Biosurgical Systems, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 27, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 18, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 27, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Integrity Biosurgical Systems, Inc.
- FDA Inspection 1072880 - 2018-11-27
- FDA Inspection 942751 - 2015-09-18
- FDA Inspection 824833 - 2013-03-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.